These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 16616700
41. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties. Patacchini R, Quartara L, Rovero P, Goso C, Maggi CA. J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857 [Abstract] [Full Text] [Related]
42. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Salthun-Lassalle B, Traver S, Hirsch EC, Michel PP. Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032 [Abstract] [Full Text] [Related]
43. Depolarization evoked co-release of tachykinins from enteric nerves in the guinea-pig proximal colon. Lippi A, Santicioli P, Criscuoli M, Maggi CA. Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):245-51. PubMed ID: 9550295 [Abstract] [Full Text] [Related]
44. NK2 tachykinin receptors mediate contraction of the pig intravesical ureter: tachykinin-induced enhancement of non-adrenergic non-cholinergic excitatory neurotransmission. Bustamante S, Orensanz LM, Barahona MV, García-Sacristán A, Hernández M. Neurourol Urodyn; 2001 Mar; 20(3):297-308. PubMed ID: 11385696 [Abstract] [Full Text] [Related]
45. Evidence that tachykinin NK2 receptors modulate resting tone in the rat isolated small intestine. Maggi CA, Giuliani S. Br J Pharmacol; 1996 Jul; 118(5):1262-8. PubMed ID: 8818352 [Abstract] [Full Text] [Related]
46. Tachykininergic excitatory neurotransmission in the pig intravesical ureter. Bustamante S, Orensanz LM, Barahona MV, Contreras J, García-Sacristán A, Hernández M. J Urol; 2000 Oct; 164(4):1371-5. PubMed ID: 10992417 [Abstract] [Full Text] [Related]
47. A role for tachykinins in female mouse and rat reproductive function. Pintado CO, Pinto FM, Pennefather JN, Hidalgo A, Baamonde A, Sanchez T, Candenas ML. Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411 [Abstract] [Full Text] [Related]
48. Tachykinin NK1 and NK2 receptors mediate inhibitory vs excitatory motor responses in human isolated corpus cavernosum and spongiosum. Patacchini R, Barbagli G, Palminteri E, Lazzeri M, Turini D, Maggi CA. Br J Pharmacol; 2002 Mar; 135(6):1351-4. PubMed ID: 11906947 [Abstract] [Full Text] [Related]
49. Comparison of antagonist activity of spantide family at human neurokinin receptors measured by aequorin luminescence-based functional calcium assay. Janecka A, Poels J, Fichna J, Studzian K, Vanden Broeck J. Regul Pept; 2005 Nov; 131(1-3):23-8. PubMed ID: 15990182 [Abstract] [Full Text] [Related]
50. Interactions of serotoninergic, cholinergic, and tachykinin-containing nerve elements in the rabbit small intestine. Dénes V, Wilhelm M, Németh A, Gábriel R. Anat Rec (Hoboken); 2009 Oct; 292(10):1548-58. PubMed ID: 19685504 [Abstract] [Full Text] [Related]
51. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers. Brunelleschi S, Nicali R, Lavagno L, Viano I, Pozzi E, Gagliardi L, Ghio P, Albera C. Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968 [Abstract] [Full Text] [Related]
52. Tachykinins are involved in local reflex modulation of vagally mediated striated muscle contractions in the rat esophagus via tachykinin NK1 receptors. Shiina T, Shimizu Y, Boudaka A, Wörl J, Takewaki T. Neuroscience; 2006 May 12; 139(2):495-503. PubMed ID: 16458437 [Abstract] [Full Text] [Related]
53. Tachykinins and their functions in the gastrointestinal tract. Shimizu Y, Matsuyama H, Shiina T, Takewaki T, Furness JB. Cell Mol Life Sci; 2008 Jan 12; 65(2):295-311. PubMed ID: 17952369 [Abstract] [Full Text] [Related]
54. Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Menzies JR, McKee R, Corbett AD. Regul Pept; 2001 Jun 15; 99(2-3):151-6. PubMed ID: 11384776 [Abstract] [Full Text] [Related]
55. Tachykinins in the gut. Part I. Expression, release and motor function. Holzer P, Holzer-Petsche U. Pharmacol Ther; 1997 Jun 15; 73(3):173-217. PubMed ID: 9175155 [Abstract] [Full Text] [Related]
56. Influence of tachykinin NK2 receptors on intestinal sensitivity and motility in newborn rats. Tramontana M, Evangelista S, Giuliani S, Manzini S, Robelet S, Girod V, Maggi CA. Neuropeptides; 2010 Jun 15; 44(3):269-72. PubMed ID: 20137809 [Abstract] [Full Text] [Related]
57. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. Couture R, Picard P, Poulat P, Prat A. Can J Physiol Pharmacol; 1995 Jul 15; 73(7):892-902. PubMed ID: 8846427 [Abstract] [Full Text] [Related]
58. Spatial and temporal expression of tachykinins and NK1- and NK2-receptor gene during TNB induced colitis in rats. Evangelista S, Tramontana M, Maggi CA. Neuropeptides; 2008 Jul 15; 42(5-6):663-70. PubMed ID: 18715640 [Abstract] [Full Text] [Related]
59. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin. Johansson A, Liu L, Holmgren S, Burcher E. Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul 15; 370(1):35-45. PubMed ID: 15235762 [Abstract] [Full Text] [Related]
60. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Lecci A, Capriati A, Maggi CA. Br J Pharmacol; 2004 Apr 15; 141(8):1249-63. PubMed ID: 15037522 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]